Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

2.48
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
2.05
Today|||52-Week Range
10.90
+10.22%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close2.48
Today’s open2.50
Day’s range2.48 - 2.50
Volume6,835
Average volume (3 months)31,058
Market cap$14.3M
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+30.23%
Earnings growth (this year)+52.00%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+24.50%
P/E ratioNM
Price/Sales3.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BNTCBenitec Biopharma Lt...-0.04-1.72%
PZRXPhaseRx Inc-0.04-2.90%
GENEGenetic Technologies...-0.02-1.76%
CLSNCelsion Corp-0.02-3.94%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$8.8M
Annual profit (last year)-$7.8M
Net profit margin-89.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs